Ezose Sciences Integrated into Shionogi Diagnostic Business | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Glycomics firm Ezose Sciences said today it has fully aligned its business with Shionogi's Diagnostics Division following its acquisition by the Japanese pharmaceutical firm.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.